Seaport Therapeutics, Inc. (SPTX)
17.15
-1.00
(-5.51%)
USD |
NASDAQ |
Oct 12, 16:00
17.09
-0.06
(-0.35%)
After-Hours: 20:00
Seaport Therapeutics Shareholders Equity (Quarterly) : 422.60M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 422.60M |
| Date | Value |
|---|---|
| March 31, 2026 | 209.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Bristol Myers Squibb Co. | 22.32B |
| Harmony Biosciences Holdings, Inc. | 999.24M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 441.68M |
| Total Liabilities (Quarterly) | 19.08M |
| Debt to Equity Ratio | 0.0119 |
| Current Ratio | 18.00 |
| Net Debt Paydown Yield | -0.07% |